Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $420.0800 (-2%) ($419.9400 - $430.9223) on Wed. Nov. 16, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.7% (three month average) | RSI | 66 | Latest Price | $420.0800(-2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 11% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(49%) XBI(45%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -1.35% in a week (0% probabilities). VIXM(-9%) TLT(-8%) UUP(-7%) TIP(-3%) SHY(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.35% (StdDev 2.7%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $427.21(-1.67%) | 10 Day Moving Average | $398.62(5.38%) | 20 Day Moving Average | $378.87(10.88%) | To recent high | -5.5% | To recent low | 25% | Market Cap | $44.541b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |